Literature DB >> 21640487

Development and validation of the appearance and performance enhancing drug use schedule.

Tom Hildebrandt1, James W Langenbucher, Justine Karmin Lai, Katharine L Loeb, Eric Hollander.   

Abstract

Appearance-and-performance enhancing drug (APED) use is a form of drug use that includes use of a wide range of substances such as anabolic-androgenic steroids (AASs) and associated behaviors including intense exercise and dietary control. To date, there are no reliable or valid measures of the core features of APED use. The present study describes the development and psychometric evaluation of the Appearance and Performance Enhancing Drug Use Schedule (APEDUS) which is a semi-structured interview designed to assess the spectrum of drug use and related features of APED use. Eighty-five current APED using men and women (having used an illicit APED in the past year and planning to use an illicit APED in the future) completed the APEDUS and measures of convergent and divergent validity. Inter-rater agreement, scale reliability, one-week test-retest reliability, convergent and divergent validity, and construct validity were evaluated for each of the APEDUS scales. The APEDUS is a modular interview with 10 sections designed to assess the core drug and non-drug phenomena associated with APED use. All scales and individual items demonstrated high inter-rater agreement and reliability. Individual scales significantly correlated with convergent measures (DSM-IV diagnoses, aggression, impulsivity, eating disorder pathology) and were uncorrelated with a measure of social desirability. APEDUS subscale scores were also accurate measures of AAS dependence. The APEDUS is a reliable and valid measure of APED phenomena and an accurate measure of the core pathology associated with APED use. Issues with assessing APED use are considered and future research is considered.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640487      PMCID: PMC3159027          DOI: 10.1016/j.addbeh.2011.05.002

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  88 in total

1.  Exercise dependence, social physique anxiety, and social support in experienced and inexperienced bodybuilders and weightlifters.

Authors:  R Hurst; B Hale; D Smith; D Collins
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

Review 2.  Beta-endorphin response to exercise. An update.

Authors:  A H Goldfarb; A Z Jamurtas
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

Review 3.  Exercise dependence.

Authors:  D M de Coverley Veale
Journal:  Br J Addict       Date:  1987-07

4.  Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity.

Authors:  Wendy Foulds Mathes; Derrick L Nehrenberg; Ryan Gordon; Kunjie Hua; Theodore Garland; Daniel Pomp
Journal:  Behav Brain Res       Date:  2010-02-13       Impact factor: 3.332

5.  Muscle dysmorphia. An underrecognized form of body dysmorphic disorder.

Authors:  H G Pope; A J Gruber; P Choi; R Olivardia; K A Phillips
Journal:  Psychosomatics       Date:  1997 Nov-Dec       Impact factor: 2.386

6.  Oral testosterone self-administration in male hamsters: dose-response, voluntary exercise, and individual differences.

Authors:  Ruth I Wood
Journal:  Horm Behav       Date:  2002-05       Impact factor: 3.587

7.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

8.  Anabolic steroid users' attitudes towards physicians.

Authors:  Harrison G Pope; Gen Kanayama; Martin Ionescu-Pioggia; James I Hudson
Journal:  Addiction       Date:  2004-09       Impact factor: 6.526

9.  Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use.

Authors:  M S Bahrke; J E Wright; R H Strauss; D H Catlin
Journal:  Am J Sports Med       Date:  1992 Nov-Dec       Impact factor: 6.202

10.  Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  Sanna Kurling; Aino Kankaanpää; Timo Seppälä
Journal:  Behav Brain Res       Date:  2008-01-05       Impact factor: 3.332

View more
  10 in total

1.  The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.

Authors:  Tom Hildebrandt; James W Langenbucher; Adrianne Flores; Seth Harty; Heather A Berlin; Heather Berlin
Journal:  Psychol Addict Behav       Date:  2014-05-19

Review 2.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

Review 3.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

4.  Exercise reinforcement, stress, and β-endorphins: an initial examination of exercise in anabolic-androgenic steroid dependence.

Authors:  Tom Hildebrandt; Sydney Shope; Eleanna Varangis; Diane Klein; Donald W Pfaff; Rachel Yehuda
Journal:  Drug Alcohol Depend       Date:  2014-03-19       Impact factor: 4.492

5.  Appearance and performance-enhancing drugs and supplements (APEDS): Lifetime use and associations with eating disorder and muscle dysmorphia symptoms among cisgender sexual minority people.

Authors:  Jason M Nagata; F Hunter McGuire; Jason M Lavender; Tiffany A Brown; Stuart B Murray; Emilio J Compte; Chloe J Cattle; Annesa Flentje; Micah E Lubensky; Juno Obedin-Maliver; Mitchell R Lunn
Journal:  Eat Behav       Date:  2022-01-12

6.  Understanding Appearance-Enhancing Drug Use in Sport Using an Enactive Approach to Body Image.

Authors:  Denis Hauw; Jean Bilard
Journal:  Front Psychol       Date:  2017-11-29

7.  Defining the Construct of Synthetic Androgen Intoxication: An Application of General Brain Arousal.

Authors:  Tom Hildebrandt; Ashley Heywood; Daniel Wesley; Kurt Schulz
Journal:  Front Psychol       Date:  2018-03-29

8.  Female Body Dissatisfaction and Attentional Bias to Body Images Evaluated Using Visual Search.

Authors:  John Cass; Georgina Giltrap; Daniel Talbot
Journal:  Front Psychol       Date:  2020-01-22

9.  Appearance and performance-enhancing drugs and supplements, eating disorders, and muscle dysmorphia among gender minority people.

Authors:  Jason M Nagata; F Hunter McGuire; Jason M Lavender; Tiffany A Brown; Stuart B Murray; Richard E Greene; Emilio J Compte; Annesa Flentje; Micah E Lubensky; Juno Obedin-Maliver; Mitchell R Lunn
Journal:  Int J Eat Disord       Date:  2022-03-30       Impact factor: 5.791

10.  The association between muscle dysmorphia and eating disorder symptomatology: A systematic review and meta-analysis.

Authors:  Laura Badenes-Ribera; Maria Rubio-Aparicio; Julio Sánchez-Meca; Matteo Angelo Fabris; Claudio Longobardi
Journal:  J Behav Addict       Date:  2019-09-11       Impact factor: 6.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.